Evidence map›Paper›PMID 30377376›Full record

ArticleNature methods2018

Species-level functional profiling of metagenomes and metatranscriptomes.

Eric A Franzosa, Lauren J McIver, Gholamali Rahnavard, Luke R Thompson, Melanie Schirmer, George Weingart, Karen Schwarzberg Lipson, Rob Knight, J Gregory Caporaso, Nicola Segata and 1 more

Registry-linked trialAbstract read
In one paragraph

Article in Nature methods, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07169123 (Protease Regulation and Impact of Sodium as Mechanisms of Inflammation in IBD), which is not on this map. Cited by 961 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
961citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07169123 recruitingnot on this mapstarted 2025, after this paper: background citation

Protease Regulation and Impact of Sodium as Mechanisms of Inflammation in IBD

TypeobservationalSponsorMcMaster UniversityRan2025 to 2029Enrolled300ConditionsCrohns Disease
3 · Its place in the literature

Who cites it

961 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Worldwide research trends on theFrontiers in immunology · 2026
    Pooled it
  3. Trial
  4. mSystems · 2025
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

901 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Eric A FranzosaDepartment of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.ORCID http://orcid.org/0000-0002-8798-7068
Lauren J McIverDepartment of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Gholamali RahnavardDepartment of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.ORCID http://orcid.org/0000-0002-9710-0248
Luke R ThompsonDepartment of Pediatrics, University of California San Diego, San Diego, CA, USA.ORCID http://orcid.org/0000-0002-3911-1280
Melanie SchirmerDepartment of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.ORCID http://orcid.org/0000-0001-6456-3679
George WeingartDepartment of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Karen Schwarzberg LipsonPathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, USA.
Rob KnightDepartment of Pediatrics, University of California San Diego, San Diego, CA, USA.ORCID http://orcid.org/0000-0002-0975-9019
J Gregory CaporasoPathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, USA.ORCID http://orcid.org/0000-0002-8865-1670
Nicola SegataCentre for Integrative Biology, University of Trento, Trento, Italy.ORCID http://orcid.org/0000-0002-1583-5794
Curtis HuttenhowerDepartment of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA. chuttenh@hsph.harvard.edu.ORCID http://orcid.org/0000-0002-1110-0096

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
Characterizing the gut microbial ecosystem for diagnosis and therapy in IBDU54DE023798 · NIDCR · BROAD INSTITUTE, INC. · PI HUTTENHOWER, CURTIS, XAVIER, RAMNIK J · 2013 to 2014
$3.0M
NIDCR NIH HHS U54 DE023798NIDDK NIH HHS P30 DK043351
6 · The paper itself

Abstract

Functional profiles of microbial communities are typically generated using comprehensive metagenomic or metatranscriptomic sequence read searches, which are time-consuming, prone to spurious mapping, and often limited to community-level quantification. We developed HUMAnN2, a tiered search strategy that enables fast, accurate, and species-resolved functional profiling of host-associated and environmental communities. HUMAnN2 identifies a community's known species, aligns reads to their pangenomes, performs translated search on unclassified reads, and finally quantifies gene families and pathways. Relative to pure translated search, HUMAnN2 is faster and produces more accurate gene family profiles. We applied HUMAnN2 to study clinal variation in marine metabolism, ecological contribution patterns among human microbiome pathways, variation in species' genomic versus transcriptional contributions, and strain profiling. Further, we introduce 'contributional diversity' to explain patterns of ecological assembly across different microbial community types.

Indexed as

Gene Expression ProfilingMetagenomeSoftwareTranscriptomeBacteriaBacterial ProteinsHigh-Throughput Nucleotide SequencingHumansMicrobiotaSpecies SpecificityBacterial Proteins

Identifiers

PMID30377376
PMCPMC6235447

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.